Next 10 |
Marks major milestone prior to launch in U.S. market PressureSafe ™ s canner and disposable pack both listed with FDA PressureSafe ™ can support early detection of pressure injuri...
Incidence of pressure injuries reduced by 50% during the study period As a decision support device, PressureSafe, can support early detection of pressure injuries, potentially setting a new standard of care to address a healthcare challenge that costs $26.8 billion annually in the U.S...
Final results to be reported from a study conducted at two medical centers owned by Clalit, the world’s second largest health maintenance organization (HMO) and the largest in Israel PressureSafe, for the detection of pressure injuries, addresses a healthcare challenge that cos...
PressureSafe, for the early detection of pressure injuries, addresses a healthcare challenge that costs $26.8 billion and causes 60,000 deaths annually in the U.S. alone Non-invasive device to augment visual inspection found to be more than 90% accurate in detecting pressure injuries ...
The Granted patent covers IR-MED’s PressureSafe ™ decision support device for the early detection of pressure injuries addressing a healthcare burden that amounts to $26.8 billion in the U.S. annually with a non-invasive device that offers more than 90% accuracy ...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
2023-10-04 16:11:49 ET More on IR-Med Inc. Historical earnings data for IR-Med Inc. Financial information for IR-Med Inc. For further details see: IR-MED appoints Tzur Di-Cori as CEO
Mr. Di-Cori’s vast healthcare experience includes President of LifeWatch Technologies, a developer of technologies that help physicians detect symptoms before they become major health problems Rosh Pina, Israel, Oct. 04, 2023 (GLOBE NEWSWIRE) -- IR-MED Inc. , (“IR-MED...
Study to address the substantial challenge of healthcare in equ ali ty in the early detection of pressure injuries in people of dark skin tones PressureSafe, a skin-color agnostic decision support device, uses AI ...
Rosh Pina, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven infrared spectrographic analysis technology platform to address significant healthcare needs, today issued the following upd...
News, Short Squeeze, Breakout and More Instantly...
IR-Med Inc Company Name:
IRME Stock Symbol:
OTCMKTS Market:
By Thomas Kerr, CFA IR-Med (OTC: IRME) released its annual 10-K filing on April 1, 2024 and the results were largely in line with expectations. The...
Marks major milestone prior to launch in U.S. market PressureSafe ™ s canner and disposable pack both listed with FDA PressureSafe ™ can support early detection of pressure injuri...
Incidence of pressure injuries reduced by 50% during the study period As a decision support device, PressureSafe, can support early detection of pressure injuries, potentially setting a new standard of care to address a healthcare challenge that costs $26.8 billion annually in the U.S...